[1]
“The effectiveness of olmesartan on inflammation at cardiopulmonary bypass ”, Ann Med Res , vol. 28, no. 1, pp. 0031–0036, May 2021, Accessed: Apr. 04, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/357